Your keyboard may be home to disease-carrying vermin

New York, May 14 (ANI): The next time you decide to eat at your desk, think again – it may be a source of disease-carrying vermin that can cause food poisoning.

These germs survive on the breadcrumbs and other food that drop inside of your keyboard while you snack, and then transmit harmful bacteria like E. coli, coliforms and enterobacteria through their droppings.

The Royal Society of Chemistry says dirty workspaces are real health hazards.

Workers who fail to keep their desk area clean and crumb-free can get sick simply by typing on a pooped-on keyboard and then picking up a sandwich or piece of fruit with their unwashed hands, the researchers warn.

They warned that mice droppings could also fall between the keys as the rodents snoop around.

“You always have to be careful,” The New York Daily News quoted Eiesha Earlington, a financial planner who lives in Woodbridge, N.J.

“On some desks you can see the germs and the dirt creates a little fingerprint, and that”s just gross,” she said.

She added: “It”s disgusting. I usually don”t like to have anybody else at my desk except for me.

“I”m definitely the one with the worst desk in the office,” said Dawn Bruent, 40, a claims adjustor who lives in Bensonhurst, Brooklyn. “I found ants on my desk once.

“I eat at my desk every day and spend about seven hours at my keyboard.

“I haven”t cleaned my desk in about eight months.

“I guess I need to clean it – maybe I will do that tomorrow.” (ANI)

Plant roots ‘can purify dirty water’

Washington, May 6 (ANI): A group of horticulturists claim to have discovered that plant roots can, to a limited degree, purify dirty washing machine water.

According to the Penn State horticulturists, plant roots enmeshed in layers of discarded materials inside upright pipes can purify dirty water from a washing machine, making it fit for growing vegetables and flushing toilets.

“Our global fresh water supplies are fast depleting,” said Robert D. Cameron, doctoral student in horticulture. “So it is critical that we begin to look at alternatives on how we can take wastewater and turn it into a resource.”

Cameron and Robert D. Berghage, associate professor of horticulture, use discarded materials and a combination of plant and bacterial communities to treat water from a washing machine and other wastewater.

According to Cameron, this design is superior to previous living treatment systems in that it requires much less space and is much more efficient at removing contaminants.

“We have shown that with this system we can take wastewater from a washing machine and remove more than 90 percent of the pollutants within three days,” said Cameron. “The treated water had very low levels of suspended solids and no detectable levels of e.coli.”

Cameron presented the work at a meeting on organic and sustainable agriculture in Havana. (ANI)

Putting an end to bacterial antibiotic resistance

Washington, April 26 (ANI): An American scientist believes some drug combinations can stop or even reverse bacterial antibiotic resistance.

Harvard researcher Roy Kishony said: “Normally, when clinicians administer a multi-drug regimen, they do so because the drugs act synergistically and speed up bacterial killing.”

However, Kishony”s laboratory has focused on the opposite phenomenon: antibiotic interactions that have a suppressive effect, namely when the combined inhibitory effect of using the two drugs together is weaker than that of one of the drugs alone.

Kishony and his team identified the suppressive interaction in E. coli, discovering that a combination of tetracycline – which prevents bacteria from making proteins – and ciprofloxacin – which prevents them from copying their DNA – was not as good as slowing down bacterial growth as one of the antibiotics (ciprofloxacin) by itself.

Kishony notes that this suppressive interaction can halt bacterial evolution, because any bacteria that develop a resistance to tetracycline will lose its suppressive effect against ciprofloxacin and die off; therefore, in a population the bacteria that remain non-resistant become the dominant strain.

While such a weakened antibiotic combination is not great from a clinical standpoint, the Kishony lab is using this discovery to set up a drug screening system that could identify novel drug combinations that could hinder the development of resistance but still act highly effectively.

He said: “Typical drug searches look for absolute killing effects, and choose the strongest candidates.

“Our approach is going to ask how these drugs affect the competition between resistant versus sensitive bacterial strains.”

To develop such a screen, Kishony and his group first had to figure how this unusual interaction works.

Kishony said: “Fast growing bacteria like E. coli are optimized to balance their protein and DNA activity to grow and divide as quickly as the surrounding environment allows.

“However, when we exposed E. coli to the ciprofloxacin, we found that their optimization disappeared.”

He went on: “We expected that since the bacteria would have more difficulty copying DNA, they would slow down their protein synthesis, too.

“But they didn”t; they kept churning out proteins, which only added to their stress.”

However, once they added the tetracycline and protein synthesis was also reduced in the E. coli, they actually grew better than before.

They then confirmed the idea that production of ribosomes – the cell components that make proteins – is too high under DNA stress by engineering E. coli strains that have fewer ribosomes than regular bacteria.

While these mutants grew a more slowly in normal conditions, they grew faster under ciprofloxacin inhibition of DNA synthesis.

Kishony believes their preliminary work on the development of a screen for drugs that put resistance in a disadvantage looks promising, and hopes that it would lead to the identification of novel drugs that select against resistance.

Kishony discussed his work at the American Society for Biochemistry and Molecular Biology”s annual meeting, titled “Driving backwards the evolution of antibiotic resistance,” on April 25. (ANI)

Bacterial defense mechanism code cracked

London, April 26 (ANI): American scientists have successfully discovered how some bacteria develop structures on their surfaces that enable them to cause disease and protect themselves from the body”s defences simultaneously.

The researchers are the first to reproduce a specific component of this natural process in a test tube, which is necessary to completely understanding how these structures grow.

The new method will allow researchers to delve even deeper into the various interactions that must occur for these structures – called lipopolysaccharides – to form, potentially discovering new antibiotic targets along the way.

Lipopolysaccharides are composed primarily of polysaccharides – strings of sugars that are attached to bacterial cell surfaces.

They help bacteria hide from the immune system and also serve as identifiers of a given type of bacteria, making them attractive targets for drugs.

But before a drug can be designed to inhibit their growth, scientists must first understand how polysaccharides are developed in the first place.

Lead author Robert Woodward, a graduate student in chemistry at Ohio State University, said: “We were able to answer some of the questions about how components of this growth system do their jobs. This will allow us to more fully characterize lipopolysaccharide biosynthesis in vitro, a process which may shed light on useful targets for developing antibiotic agents.”

The scientists used a harmless strain of Escherichia coli as a model for this work, which would apply to other E. coli strains and similar Gram-negative bacteria, a reference to how their cell walls are structured.

The surface of these bacteria house the lipopolysaccharide, which is a three-part molecular structure embedded into the cell membrane.

Two sections of this structure are well understood, but the third, called the O-polysaccharide, has to date been impossible to reproduce.

Two significant challenges have hindered research efforts in this area – the five sugars strung together to compose this section of the molecule are difficult to chemically prepare in the lab, and one of the key enzymes that initiates the structure”s growth process doesn”t easily function in a water-based solution in a test tube.

Ohio State synthetic chemists and biochemists put their heads together to solve these two problems, Woodward said.

To produce the five-sugar chain, the researchers started with a chemically prepared building block containing a single sugar and introduced enzymes that generated a five-sugar unit from that single carbohydrate.

Woodward said: “The first part was done chemically, and in the second part, we used the exact same enzymes that are normally present in a bacterial cell to transform the single sugar into a five-sugar string.”

Once these sugars join to make a five-sugar chain, a specific number of these chains are joined together to fully form the O-polysaccharide.

A protein is required to connect those chains – the protein that doesn”t respond well to the test-tube environment.

Early attempts to produce this protein in the lab resulted in clumping structures that did not function. So Woodward and colleagues produced this protein in the presence of what are known as “chaperone” proteins.

Woodward said: “And basically what the chaperones do is help the protein fold into its correct state. We were able to produce the desired enzyme and also were able to verify that it was functional,”

This protein is called Wzy. It is a sugar polymerase, or an enzyme that interacts with the five-sugar chain to begin the process of linking several five-sugar units together.

Getting this far into the process was important, but the researchers also completed one additional step to define yet another protein”s role.

Wzy connected the five-sugar chains, but it did so with no defined limit to the number of five-sugar units involved, a feature that does not match the natural process.

On an actual bacterial cell wall, the length of the polysaccharide falls within a relatively narrow range of the number of chains connected.

So the scientists introduced another protein, called Wzz, to the mixture. This protein is known as a “chain length regulator.”

With this protein in the mix, the lengths of the resulting polysaccharides were confined to a much more narrow range.

Woodward said: “We were able to replicate the exact polysaccharide biosynthetic pathway in vitro, getting the correct lengths.

“This is important because now you can begin to look at a whole host of other properties in the system.”

The group already started trying to answer one compelling question: whether the two proteins, Wzy and Wzz, have to interact to fully achieve formation of the polysaccharide.

Woodward said: “We”ve shown in some preliminary results that they do interact, but we haven”t determined whether that interaction has any functional relevance.”

After this study, researchers now have access to information about how all three parts of the lipopolysaccharide, the large biomolecule on Gram-negative bacteria cell surfaces, are formed.

The research has appeared in the online edition of the journal Nature Chemical Biology. (ANI)

Bile sends mixed signals to gut bacteria for boosting survival

Washington, Apr 1 (ANI): In the small intestine, bile secretions send signals to disease causing gut bacteria enabling them to change their behaviour to extend their chances of survival, according to a Montana State University scientist.

The findings by Steve Hamner and colleagues could allow us to better protect food from contamination by these harmful bacteria, as well as understand how they manage to cause disease.

Bile is secreted into the small intestine and exerts an antibacterial effect by disrupting bacterial membranes and damaging bacterial DNA, said the study.

While bile is a human defense mechanism, the researchers found that some bacteria such as Escherichia coli O157:H7 — an important food-borne pathogen known as E. coli — have evolved to use the signal to their advantage.

These bacteria use the presence of bile as a signal to tell them that they are in the intestine, which allows them to adapt and prepare to cause disease.

They found that bile causes the bacteria to switch on genes needed to increase iron uptake.

“This is useful in iron-scarce environments — such as the small intestine — as iron is an essential nutrient for bacterial growth. By increasing its chances of absorbing iron, the bacterium is maximizing its survival chances,” explained Hamner.

E. coli O157:H7 primarily infects the large intestine, and this study provides one explanation why this is the case.

“We found that bile causes the bacteria to turn off genes that promote tight attachment to host cells. Bile may effectively prevent these bacteria from latching onto the epithelial cells that line the small intestine,” suggested Hamner.

As bacteria move further down the digestive tract towards the large intestine, the concentration of bile decreases.

“The reduced concentration of bile in the large intestine may then be a signal for the bacteria to switch on their ability to attach to epithelial cells and to prepare to secrete toxins,” said Hamner.

Studying the conditions that make these bacteria more likely to attach themselves to cells could help reduce outbreaks of food poisoning.

“By learning how the bacteria attach to food surfaces such as spinach leaves or to host tissues such as the lining of the intestine, we hope to better be able to protect food sources from contamination by these bacteria. Studying how these bacteria interact with hosts such as humans or cows could teach us how to interfere with the way that these bacteria cause disease,” said Hamner.

The study was presented at the Society for General Microbiology during its spring meeting in Edinburgh, Scotland. (ANI)

Scientist develop new 2-in-1 test for E.coli detection in food

Washington, March 24 (ANI): American scientists have developed a 2-in-1 test for detecting E. coli in ground beef and other foods.

The test, which can also help detect the toxins or poisons that the bacteria use to cause nausea, vomiting and diarrhoea, was described at the 239th National Meeting of the American Chemical Society (ACS) in San Francisco.

E. coli O157 may be present in food for hours or days before improper storage conditions allow them to grow and produce the toxins that actually cause food poisoning. Those toxins can remain in food even after the bacteria are dead and gone. Earlier, it took separate tests to protect against this double threat from the bacteria and the toxins.

Project leader John Mark Carter, who is with the U.S. Department of Agriculture”s Agricultural Research Service in Albany, Calif., said: “Our test may be used in meat processing plants to allow in-house testing of products prior to sale.

“This would reduce the frequency of foodborne illness, reduce product recalls, and enhance public health while reducing annual cost for food testing.”

While E. coli O157 outbreaks have involved foods such as lettuce, spinach, tomatoes, and peanut butter, ground beef remains a major concern. The bacteria may get into ground beef when meat is contaminated with faecal material from chickens or cattle during slaughtering or processing. If the meat is not properly chilled, the bacteria may multiply and produce enough of two main toxins — called Shiga toxin 1 and Shiga toxin 2 — to cause illness.

Until now, there was no two-in-one test for the bacteria and the toxins. Separate tests were required for each threat. Current tests for E. coli in beef also are time-consuming. The results take 3 to 5 days. But researchers say the new test cuts the waiting time to just 24 hours.

The new test uses microscopic plastic beads, each 1/100th the width of a grain of sand, containing a fluorescent dye. The beads, customized in Carter”s lab, are coated with antibodies that lock onto proteins or antigens present on E. coli and its two main toxins. During the test, the beads are mixed together with ground beef or other food samples and then separated and run through an instrument. It identifies beads that have latched onto the E. coli antigens.

Carter said: “Finding a few E. coli bacteria in a large sample of ground beef or other food is like looking for a needle in a haystack.

“This new method makes the needle much easier to find, compared to standard methods. But improvements in sampling and sensitivity are still needed.” (ANI)

Garibaldi contamination victims receive payouts

More than half the court cases arising out of the Garibaldi contamination case in South Australia have been settled, 13 years after they began.

Eight of the 15 District Court cases for personal damages have settled for undisclosed amounts, although court records show one of the payouts is more than $1.8 million.

The claims were brought by people, mainly children, who ate Garibaldi smallgoods contaminated with E. coli bacteria in 1995.

Four-year-old Nikki Robinson died and more than 20 children fell seriously ill.

Many of the surviving victims continue to suffer severe health problems. One is currently recovering from multiple organ transplants.

Another seven court cases are unresolved and have been scheduled for a joint hearing in June.

E. coli source remains a mystery

The acting director of Gold Coast Water, Darren Hayman, says it is not clear how E. coli got into the drinking water supply at Nerang.

People at 2,500 properties had to boil their drinking water over the weekend.

That requirement was lifted yesterday but Mr Hayman says the hunt for the source of the contamination is continuing.

He says inspections have cleared pipes and reservoirs in the area but the water quality tests that raised the original alarm may be suspect.

“It requires a very stringent controlled environment to collect that test – in a sterile environment – and it’s possible that sometimes those tests can be corrupted,” he said.

“The tests we have taken since Friday have definitely indicated a clear result.”

Nerang water ‘all clear’ to drink

Authorities say there is no longer a need for Nerang residents on Queensland’s Gold Coast to boil their drinking water.

The alert was issued last Friday after E. coli bacteria was found in some supplies.

The Gold Coast City Council says it has yet to determine what caused the problem.

Hope for boil water alert to be lifted

Gold Coast city councillor Peter Young says he expects Nerang residents on the Gold Coast can stop boiling drinking water today.

Council says E. coli was found during testing last week and 2,500 properties were affected.

Cr Young says he expects the all-clear should be given later today.

“Three tests have been undertaken over the weekend and all clear and based on that the council and the Department of Health decided to lift the notice but that was revoked so the notice stays in place until another clear test which will hopefully be today and then we can issue the all-clear,” he said.

Study sheds light on fundamental DNA repair mechanism

Washington, March 5 (ANI): A team of researchers has demonstrated for the first time the specific activity of the protein NEIL3, one of a group responsible for maintaining the integrity of DNA in humans and other mammals.

Since it was first identified about eight years ago, NEIL3 has been believed to be a basic DNA-maintenance enzyme of a type called a glycosylase.

These proteins patrol the long, twisted strands of DNA looking for lesions-places where one of the four DNA bases has been damaged by radiation or chemical activity.

They cut the damaged bases free from the DNA backbone, kicking off follow-on mechanisms that link in the proper undamaged base.

The process is critical to cell health, says National Institute of Standards and Technology (NIST) biochemist and Senior Research Fellow Miral Dizdaroglu.

“DNA is damaged all the time. About one to two percent of oxygen in the body becomes toxic in cells, for example, creating free radicals that damage DNA. Without these DNA repair mechanisms there wouldn”t be any life on this planet, really.”

The glycosylases seem to be highly specific; each responds to only a few unique cases of the many potential DNA base lesions. Figuring out exactly which ones can be challenging. NEIL3 and its kin NEIL1 and NEIL2 are mammalian versions of an enzyme found in the bacterium E. coli.

The lesion targets of NEIL1 and NEIL2 have been known for some time, but NEIL3, a much more complicated protein twice the size of the others, had resisted several attempts to purify it and determine just what it does.

In a significant advance, the research team managed to clone the house mouse version of NEIL3 (99 percent identical to the human variant), and then prepare a truncated version of it that was small enough to dissolve in solution for analysis but large enough to retain the portion of the protein that recognizes and excises DNA lesions.

Using a technique they developed for rapidly analyzing such enzymes, NIST researchers mixed the modified protein with sample DNA that had been irradiated to produce large numbers of random base lesions.

Because glycosylases work by snipping off damaged bases, a highly sensitive analysis of the solution after the DNA has been removed can reveal just which lesions are attacked by the enzyme, and with what efficiency.

The NIST results closely matched independent tests by others in the team that match the enzyme against short lengths of DNA-like strands with a single specific target lesion.

In addition to finally confirming the glycosylase nature of NEIL3, tests of the enzyme in a living organism-a tailored form of E. coli designed to have a very high mutation rate-had an unexpected bonus.

Measurements at NIST showed that NEIL3 is extremely effective at snipping out a particular type of lesion called FapyGua and seems to dramatically reduce mutations in the bacterium, a result that points both to the effectiveness of NEIL3 and the potentially important role of FapyGua in causing dangerous mutations in DNA. (ANI)

Vaccine for urinary tract infections comes closer to reality

Washington, Sept 18 (ANI): A simple vaccine may soon be available to protect against urinary tract infections, thanks to researchers from University of Michigan.

The study conducted over mice showed that the vaccine prevented infection and produced key types of immunity.

It alerts the immune system to iron receptors on the surface of Escherichia coli bacteria that perform a critical function allowing infection to spread.

Administered in the nose, it induces an immune response in the body’s mucosa, a first line of defense against invading pathogens. The response, also produced in mucosal tissue in the urinary tract, should help the body fight infection where it starts.

The researchers used novel systematic approach, combining bioinformatics, genomics and proteomics, to look for key parts of the bacterium that could be used in a vaccine to elicit an effective immune response.

The team, led by Dr. Harry L.T. Mobley, screened 5,379 possible bacterial proteins and identified three strong candidates to use in a vaccine to prime the body to fight E. coli.

Mobley’s team is currently testing more strains of E. coli obtained from women treated at U-M.

If the robust immunity achieved in mice can be reproduced in humans, it could be the first ever vaccine for urinary tract infections.

Most of the strains produce the same iron-related proteins that can be vaccine targets, an encouraging sign that the vaccine could work against many urinary tract infections.

The findings are published in the open-access journal PLoS Pathogens. (ANI)

Scientists developing probiotics to ambush disease-causing gut bacteria

Washington, Sept 8 (ANI): Scientists from University of Adelaide are working on developing diversionary tactics in a bid to fool disease-causing gut bacteria that often lead to infections, such as cholera.

According to Professor James Paton, bacteria produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host’s intestine.

In the new study, researchers have shown how they had added molecular mimics of these host cell receptors onto the surface of harmless bacteria capable of surviving in the human gut.

If given during an infection caused by a toxin-producing bacterium, these “receptor-mimic probiotics” will bind the toxins in the gut very strongly, thereby preventing the toxins from interacting with receptors on host intestinal cells and causing disease.

An advantage of this approach to treatment is that the pathogenic bacteria are unlikely to develop a resistance to it, as that would destroy the basic mechanism by which they cause disease.

Moreover, receptor-mimic bacteria bind toxins more strongly than previous technologies.

They are also more cost effective, as the bacteria can be grown cheaply in large-scale fermenters.

“We initially developed this technology to prevent disease caused by strains of E. coli bacteria that produce Shiga toxin. These include the infamous E. coli O157 strain, which causes outbreaks of severe bloody diarrhoea and the potentially fatal haemolytic uraemic syndrome,” said Paton.

“Our prototype receptor mimic probiotic provided 100% protection against otherwise fatal E. coli disease in an animal model. We have also developed similar receptor mimic probiotics that are capable of preventing cholera and travellers’ diarrhoea.

“As well as being able to treat disease, these probiotics could be given to vulnerable populations following natural disasters to help prevent outbreaks of diseases like cholera,” he added.

The findings were presented at the Society for General Microbiology’s meeting at Heriot-Watt University, Edinburgh. (ANI)

Scientists use waste to recover uranium from polluted waters

Washington, September 7 (ANI): Researchers at Birmingham University, UK, using bacteria and inositol phosphate, a chemical analogue of a cheap waste material from plants, have recovered uranium from the polluted waters from uranium mines.

Bacteria, in this case, E. coli, break down a source of inositol phosphate (also called phytic acid), a phosphate storage material in seeds, to free the phosphate molecules.

The phosphate then binds to the uranium forming a uranium phosphate precipitate on the bacterial cells that can be harvested to recover the uranium.

This process was first described in 1995, but then a more expensive additive was used and that, combined with the then low price of uranium, made the process uneconomic.

The discovery that inositol phosphate was potentially six times more effective as well as being a cheap waste material means that the process becomes economically viable, especially as the world price of uranium is likely to increase as countries move to expand their nuclear technologies in a bid to produce low-carbon energy.

As an example, if pure inositol phosphate, bought from a commercial supplier is used, the cost of this process is 1.72 pounds per gram of uranium recovered.

If a cheaper source of inositol phosphate is used (for example calcium phytate), the cost reduces to 0.09 pounds for each gram of recovered uranium.

At 2007 prices, uranium cost 0.211 pounds per gram; it is currently 0.09 pounds per gram.

These prices make the process economic overall because there is also an environmental protection benefit.

Use of low-grade inositol phosphate from agricultural wastes would bring the cost down still further and the economic benefit will also increase as the price of uranium is forecast to rise again.

According to Professor Lynne Macaskie, “The UK has no natural uranium reserves, although a significant amount of uranium is produced in nuclear wastes. There is no global shortage of uranium, but from the point of view of energy security, the EU needs to be able to recover as much uranium as possible from mine run-offs, as well as recycling as much uranium as possible from nuclear wastes.”

“By using a cheap feedstock easily obtained from plant wastes, we have shown that an economic, scalable process for uranium recovery is possible,” Macaskie said. (ANI)

Oregano, garlic essential oils can be effective barriers against E. coli

Washington, Sept 6 (ANI): Essential oils from common spices like oregano, allspice and garlic can act as a natural barrier against bacteria like E-Coli, Salmonella and Listeria, according to a new US government study.

Oregano oil has been found to be the most effective antimicrobial, followed by allspice and garlic.

Researchers at Processed Foods Research and Produce Safety and Microbiology units of Western Regional Research Centre from the U.S. Department of Agriculture (USDA) investigated the effectiveness of the oils by incorporating them in thin, tomato-based antimicrobial coatings known as edible films.

In addition to its flavour properties, tomatoes are reported to possess numerous beneficial nutritional and bioactive components that may benefit human health.

Edible tomato films containing antimicrobials may protect food against contamination by pathogenic microorganisms.

The findings revealed that oregano oil consistently inhibited the growth of all three bacteria.

Although garlic oil was not effective against E. coli or Salmonella, but was effective against Listeria.

Vapour tests of oregano and allspice oils indicated that these two oils diffuse more efficiently through the air than through direct contact with the bacteria.

Listeria was less resistant to EO vapors while E. coli was more resistant.

“The results show that apple-based films with allspice, cinnamon or clove bud oils were effective against the three bacteria. The essential oils have the potential to provide multiple benefits to consumers,” said lead researcher R. J. Avena-Bustillos.

The study appears in Journal of Food Science. (ANI)

Findings on how bladder cells detect bacteria may help prevent urinary tract infections

Washington, August 21 (ANI): Researchers at Duke University Medical Center may be close to devising a new way to stop or prevent the urinary tract infections (UTIs), for they have discovered how cells within the bladder are able to sense the presence of E. coli bacteria hiding within their compartments.

They think that knowing how the bladder’s own cells sense the bacteria, and what they do to expel them, can prove helpful in enabling the bladder to protect itself.

Soman Abraham, a professor of pathology at Duke, believes that new treatments based on the research team’s findings may be able to tackle antibiotic-resistant UTIs, and perhaps even bacterial infections in other parts of the body.

The findings have been published in the Proceedings of the National Academy of Sciences. (ANI)

Light-activated antibacterial coating may help fight hospital-acquired infections

Washington, Mar 31 (ANI): Scientists at the UCL Eastman Dental Institute have developed a new tool to combat hospital-acquired infections- antibacterial coating that is activated by light.

The research team, led by Zoie Aiken, have tested the new coating with antibacterial properties, and found that it could kill 99.9 percent of Escherichia coli bacteria when a white hospital light was shone on its surface to activate it.

Made of titanium dioxide with added nitrogen, the veneer-like surface, when activated by white light-similar to those used in hospital wards and operating theatres-produced a decrease in the number of bacteria surviving on the test surface.

The hospital environment is usually full of microbes responsible for healthcare-associated infections (HCAI).

Thus, there’s a need for new ways to prevent the spread of these pathogens to patients.

And it is possible to apply antibacterial coatings to frequently touched hospital surfaces to kill any bacteria present and help reduce the number of HCAI.

Titanium dioxide based coatings can kill bacteria after activation with UV light.

And the addition of nitrogen to these coatings enables photons available in visible light to be utilised to activate the surface and kill bacteria.

Aiken said: “The activity of the coating will be assessed against a range of different bacteria such as MRSA and other organisms which are known to cause infections in hospitals. At present we only know that the coating is active against Escherichia coli. However, E. coli is more difficult to kill than bacteria from the Staphylococcus group which includes MRSA, so the results to date are encouraging.

“The coating has currently been applied onto glass using a method called APCVD (atmospheric pressure chemical vapour deposition.

“We are also experimenting with different materials such as plastic. As an example, the coating could be applied to a plastic sheet that could be used to cover a computer keyboard on a hospital ward. The lights in the ward will keep the coating activated, which will in turn continue to kill any bacteria that may be transferred onto the keyboard from the hands of healthcare workers.”

The study was presented at the Society for General Microbiology meeting in Harrogate. (ANI)

Why do people get sick when they’re stressed

Washington, Mar 10 (ANI): Ever wondered why people get sick when they’re stressed? Well, researchers at UT Southwestern Medical Centre claim to have found the answer.

While studying the diarrhea-causing strain of E coli, they identified a receptor known as QseE, which resides in the bacterium.

The receptor senses stress cues from the bacterium’s host and helps the pathogen make the host ill.

Dr. Vanessa Sperandio, associate professor of microbiology at UT Southwestern and the study’s senior author, said QseE is an important player in disease development because the stress cues it senses from a host, chiefly epinephrine and phosphate are generally associated with blood poisoning, or sepsis.

“Patients with high levels of phosphate in the intestine have a much higher probability of developing sepsis due to systemic infection by intestinal bacteria,” said Dr. Sperandio.

“If we can find out how bacteria sense these cues, then we can try to interfere in the process and prevent infection.

“There’s obviously a lot of chemical signalling between host and bacteria going on, and we have very little information about which bacteria receptors recognize the host and vice versa.

“We’re scratching at the tip of the iceberg on our knowledge of this,” she added.

According to the researchers, once QseC recognizes the stress hormones, it initiates a cascade of genetic activations in which the bacteria colonizes the intestine and moves toxins into human cells, altering the makeup of the cells and robbing the body of nutrients.

“The bacteria get what they want – nourishment – and the person ends up getting diarrhea,” Sperandio said.

“The problem may not only be that the stress signals are weakening your immune system, but that you’re also priming some pathogens at the same time,” she said.

“Then it’s a double-edged sword. You have a weakened immune system and pathogens exploiting it,” she added. (ANI)

New technique to make bacteria glow under light may help fight against breast cancer

Washington, March 8 (ANI): Michigan Technological University scientists have come up with a way to make a strain of E. coli glow under fluorescent light, a technique that may one day help track down all sorts of pathogens, and even prove beneficial in fight against breast cancer.

Associate Professor of Chemistry Haiying Liu, who led the research project, points out that E. coli bacteria are naturally found in animal intestines and are usually harmless, but when virulent strains contaminate food, they can cause serious illness and even death.

Liu’s trick takes advantage of E. coli’s affinity for the sugar mannose.

During the study, the research team attached mannose molecules to specially engineered fluorescent polymers, and stirred them into a container of water swimming with E. coli.

The researchers said that microscopic hairs on the bacteria, called pili, hooked onto the mannose molecules like Velcro, effectively coating the bacteria with the polymers.

They later shined white light onto E. coli colonies growing in the solution, and the bugs lit up like blue fireflies.

“They became very colorful and easy to see under a microscope,” said Liu.

The researcher says that this approach may help identify a wide array of pathogens by mixing and matching from a library of different sugars and polymers, which fluoresce different colours under different frequencies of light.

If blue means E. coli, they add, fuchsia may one day mean influenza.

Liu is adapting the technique to combat breast cancer also. In place of mannose, he plans to link the fluorescent polymers to a peptide that homes in on cancer cells.

He says that upon introduction to the vascular system, the polymers would travel through the body, stick to tumour cells, and then illuminated by a type of infrared light that shines through human tissue.

The researcher says that the glowing polymers would provide a beacon to pinpoint the location of the malignant cells, and allow surgeons to easily identify and remove malignant cells while minimizing damage to healthy tissue.

An article on the team’s work on E. coli has been published in the journal Chemistry. (ANI)

Engineered viruses may help fight drug-resistant superbugs

London, Mar 3 (ANI): A virus that weakens bacterial defence systems is the latest weapon in the fight against drug-resistant superbugs.

Researchers in the United States have engineered viruses to weaken the bacteria, leaving the bugs more vulnerable to antibiotics, reports Nature.

The ‘bacteriophages’ or just ‘phages’ were programmed to target a DNA repair system that allows the bacteria to survive antibiotics.

Used alongside the drugs, the viruses wipe out bacterial defences and prevent resistance from developing.
With more bacteria becoming resistant to the most commonly used antibiotics, the viral approach could extend the useful lifetime of these drugs.

Bioengineer James Collins of Boston University in Massachusetts and his then graduate student, Timothy Lu, genetically engineered a phage called M13, which does not cause infected cells to explode, to produce a bacterial protein called lexA3 – which impairs a bacterium’s ability to repair damaged DNA.

When the modified M13 phage infects a bacterium, in this case Escherichia coli, it produces lexA3, which renders the bacterium more vulnerable to DNA-damaging drugs.

The researchers found that the phage increased the ability of the antibiotic ofloxacin to kill E. coli grown in culture, even when the bacteria were resistant to the antibiotic on its own.

The findings suggest that this type of phage therapy could rejuvenate antibiotics that have been deemed no longer effective.

The results of the study conducted on mice were also promising.

80 percent of animals that received both ofloxacin and the modified M13 phage survived infection with a disease-causing strain of E. coli, compared with only a 20 percent survival rate among infected mice treated with the antibiotic alone. (ANI)